Skip to main content

Market Overview

Thermo Fisher Scientific: Q2 Earnings Insights



Shares of Thermo Fisher Scientific (NYSE:TMO) remained unaffected after the company reported Q2 results.

Quarterly Results

Earnings per share rose 43.96% over the past year to $5.60, which beat the estimate of $5.49.

Revenue of $9,273,000,000 higher by 34.06% from the same period last year, which beat the estimate of $8,770,000,000.


The upcoming fiscal year's EPS expected to be between $22.07 and $22.07.

The upcoming fiscal year's revenue expected to be between $35,900,000,000 and $35,900,000,000.

Conference Call Details

Date: Jul 28, 2021

Time: 08:30 AM

ET Webcast URL:


52-week high: $534.50

52-week low: $401.06

Price action over last quarter: Up 12.77%

Company Profile

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (17%); life science solutions (38%); and lab products and services (38%).


Related Articles (TMO)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at